Webinars, Pharmaceutical

Roundtable: Evolution of Pressurized Metered Dose Inhalers to Cut Carbon Emissions

Pressurized metered dose inhalers (pMDIs) for the relief of asthma and Chronic Obstructive Pulmonary Disease (COPD) are drawing more attention in sustainability conversations due to their total carbon footprint.

This roundtable meeting gathered some of the leading opinions on this multi-faceted challenge to discuss the challenges we face today and will encounter tomorrow. The topics discussed included the importance to review the lessons learnt from the CFC transition, a review of the current use of pMDIs in the treatment of asthma, the challenges associated with a transition to DPIs and the need for a collaborative approach in their development.  It also recaps the complex regulatory hurdles, challenges faced by formulation scientists, policy makers, and the economics of switching to low GWP propellants. Finally, the panelists reviewed the advantages of lower carbon footprint inhalers and the importance of patient choice and preference, which could ultimately weigh heavily in patients compliance and adherence to their asthma and COPD treatment.

Watch Roundtable video on Evolution of Pressurized Metered Dose Inhalers to Cut Carbon Emissions
Speaker(s): Prof. Omar Usmani Dr. John Pritchard Dr. Jag Shur
18 May 2022

Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery

Find Out More about Pulmonary Drug Delivery

This Might Also Be of Your Interest

24 Apr 2024

Advancing OINDP Clinical Trials with Speed and Efficiency: Strategies for Success

Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights

Read More
24 Apr 2024

Exploring Nasal Casts in Nasal Drug Development

Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights

Read More
22 Apr 2024

Navigating the Shift to more sustainable Low GWP propellants in pMDIs

Publications, Pharmaceutical, Sustainability, Brand Differentiation, Market Insights, Product Solutions

Read More
26 Mar 2024

Optimizing Preclinical Studies for Intranasal and Pulmonary Programs

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Market Insights, Product Solutions

Read More
1 2 3 20

Request Access

Close

Requesting access to Roundtable: Evolution of Pressurized Metered Dose Inhalers to Cut Carbon Emissions.

  • This field is for validation purposes and should be left unchanged.
Back To Top